Cell Penetrating Peptide Delivery of Splice Directing Oligonucleotides as a Treatment for Duchenne Muscular Dystrophy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|16|2948-2962

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.16, 2013-05, pp. : 2948-2962

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Splice Modification to Restore Functional Dystrophin Synthesis in Duchenne Muscular Dystrophy

By  

Current Pharmaceutical Design, Vol. 16, Iss. 8, 2010-03 ,pp. : 988-1001

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for Duchenne muscular dystrophy

By Malik Vinod   Rodino-Klapac Louise R.   Mendell Jerry R  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 261-277

Informa Healthcare

Access to resources Recommend Favorite

Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy

By Judge Daniel P.   Kass David A.   Thompson W. Reid   Wagner Kathryn R.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 5, 2011-10 ,pp. : 287-294

Adis International

Access to resources Recommend Favorite

Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements

By Koren Erez   Apte Anjali   Sawant Rupa R.   Grunwald Jacob   Torchilin Vladimir P.  

Drug Delivery, Vol. 18, Iss. 5, 2011-07 ,pp. : 377-384

Informa Healthcare

Access to resources Recommend Favorite

Cell-penetrating Peptide-based Intelligent Liposomal Systems for Enhanced Drug Delivery

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 3, 2014-03 ,pp. : 210-219

Bentham Science Publishers

Access to resources Recommend Favorite